Clinical Variant of Guillain–Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine : Journal of Clinical Neuromuscular Disease

Secondary Logo

Journal Logo

Letters to the Editor

Clinical Variant of Guillain–Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine

Badoiu, Anca MD*; Moranne, Olivier MD, PhD; Coudray, Sarah MD; Ion, Ioana Maria MD*

Author Information
Journal of Clinical Neuromuscular Disease 23(2):p 115-116, December 2021. | DOI: 10.1097/CND.0000000000000383
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid